NOTICE OF BREACH AND DEMAND FOR DISPUTE RESOLUTIONClinical Development and License Agreement • August 31st, 2006 • Biodelivery Sciences International Inc • Pharmaceutical preparations
We make reference to the Clinical Development and License Agreement, dated as of July 14, 2005, among BioDelivery Sciences International, Inc., (“BDSI”), Clinical Development Capital LLC (together with its successors and assigns, including, without limitation, CDC IV, LLC, collectively, “CDC”), and Arius Pharmaceuticals, Inc. (such agreement, as amended, the “CDLA”). All capitalized terms used but not defined herein shall have the meanings assigned to such terms in the CDLA.
